Insider Trading & Ownership - Cross John Harry III

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cross John Harry III

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-07
Option Award
2025-03-11
4:14 pm
N/A
2035-03-06
Senti Biosciences Inc.SNTICross John Harry III
Chief Financial Officer
174,200$0174,200
(Direct)
View
2023-12-11
Option Award
2024-12-05
9:55 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc.SONNCross John Harry III
Chief Financial Officer
1,452$01,588
(Direct)
View
2023-02-06
Tax Withholding
2023-02-17
4:45 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc.SONNCross John Harry III
Chief Financial Officer
1,960$1.0623,927
(Direct)
View
2022-12-14
Option Award
2022-12-22
4:31 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc.SONNCross John Harry III
Chief Financial Officer
15,519$0160,684
(Direct)
View
2021-12-15
Option Award
2022-04-08
4:30 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc.SONNCross John Harry III
Chief Financial Officer
66,951$0145,165
(Direct)
View